North America Deep Partial-Thickness Thermal Burns Treatment Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

North America Deep Partial-Thickness Thermal Burns Treatment Market Segmentation, By Burn Type (Fire Burn Injuries, Scald Burn, and Hot Objects), Treatment (Initial Wound Care, Physical and Occupational Therapy, and Others), Route of Administration (Topical, Oral, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others) - Industry Trends and Forecast to 2032

North America Deep Partial-Thickness Thermal Burns Treatment Market Size

• The North America deep partial-thickness thermal burns treatment market size was valued at USD 832.69 million in 2024 and is expected to reach USD 1,683.71 million by 2032, at a CAGR of 9.20% during the forecast period
• The market growth is largely fueled by the increasing incidence of burn injuries, advancements in wound care and regenerative medicine technologies, and rising awareness about specialized burn treatment options in North America
• Furthermore, the presence of well-established healthcare infrastructure, including specialized burn centers and hospitals equipped with advanced burn treatment facilities, is driving the adoption of effective treatment solutions, thereby significantly boosting the industry's growth

North America Deep Partial-Thickness Thermal Burns Treatment Market Analysis

• Deep partial-thickness thermal burns treatment, including advanced wound care products, skin substitutes, and regenerative therapies, is increasingly vital in improving patient outcomes and reducing complications in both hospital and specialized burn center settings due to faster healing, minimized scarring, and infection prevention
• The escalating demand for deep partial-thickness burn treatments is primarily fueled by the rising incidence of burn injuries, growing awareness of advanced treatment options, and continuous innovations in wound care and regenerative medicine technologies
• The U.S. dominated the North America deep partial-thickness thermal burns treatment market with the largest revenue share of 68.5% in 2024, supported by well-established healthcare infrastructure, high healthcare expenditure, and the presence of leading burn care providers. Substantial adoption of advanced treatment modalities is driven by ongoing research, availability of specialized burn centers, and development of novel biologics and dressings
• Canada is expected to be the fastest growing country in the North America deep partial-thickness thermal burns treatment market during the forecast period, driven by increasing healthcare investments, growing awareness of specialized burn care, and the adoption of modern wound management technologies
• Fire burn injuries segment dominated the deep partial-thickness thermal burns treatment market in 2024 with a share of 52.5%, driven by the high incidence of fire-related accidents and the severe nature of burns that require comprehensive and advanced treatment approaches

Report Scope and North America Deep Partial-Thickness Thermal Burns Treatment Market Segmentation  

North America Deep Partial-Thickness Thermal Burns Treatment Market Trends

Advancements in Regenerative and Bioengineered Therapies

• A significant and accelerating trend in the North America deep partial-thickness thermal burns treatment market is the development and adoption of regenerative and bioengineered therapies, including skin substitutes, stem-cell-based products, and advanced dressings that accelerate healing and reduce scarring

  • For instance, bioengineered skin grafts such as Integra Dermal Regeneration Template are being increasingly used in specialized burn centers to promote faster recovery and minimize long-term complication

• These therapies improve clinical outcomes by enhancing tissue regeneration, reducing infection risks, and lowering the need for repeated surgical interventions, contributing to better patient quality of life
• The integration of these advanced treatments with conventional wound care protocols facilitates comprehensive care management, enabling clinicians to tailor interventions based on burn severity and patient needs
• This trend towards more innovative, clinically effective, and patient-friendly burn care solutions is shaping expectations for advanced burn management, with companies investing heavily in research and product development
• The demand for regenerative and bioengineered treatments is growing rapidly across both hospital and home healthcare settings as clinicians and patients increasingly prioritize faster healing, reduced scarring, and improved functional recovery

North America Deep Partial-Thickness Thermal Burns Treatment Market Dynamics

Driver

Increasing Incidence of Burn Injuries and Awareness of Advanced Care

• The rising prevalence of burn injuries across residential, occupational, and accidental settings, coupled with growing awareness of advanced treatment options, is a significant driver for the heightened demand for deep partial-thickness burn therapies

  • For instance, specialized burn centers in the U.S. have reported increasing adoption of combined wound care and regenerative therapies to manage severe burn cases efficiently

• As patients and healthcare providers seek improved outcomes, advanced wound care products, biologics, and physical therapy interventions are increasingly being integrated into standard treatment protocols
• Furthermore, the rising emphasis on reducing healing times, minimizing complications, and improving cosmetic outcomes is making regenerative and advanced burn care treatments an essential component of modern clinical practice
• The availability of specialized burn centers and highly trained clinicians in North America further supports the rapid adoption of advanced therapies, driving market growth in both hospitals and home healthcare settings
• The growing focus on patient-centered care and clinical efficacy encourages investment in novel treatments, educational initiatives, and technology adoption to improve overall burn management outcomes

Restraint/Challenge

High Cost of Advanced Treatments and Limited Access

• The relatively high cost of advanced wound care products, regenerative therapies, and specialized burn treatments poses a significant challenge to broader market penetration, particularly for price-sensitive healthcare providers or patients

  • For instance, bioengineered skin substitutes and stem-cell-based therapies are often expensive and may not be fully reimbursed by insurance providers, limiting access for some patients

• Addressing these cost barriers through insurance coverage expansion, value-based pricing strategies, and cost-effective treatment alternatives is crucial for wider adoption
• In addition, the limited availability of specialized burn centers and trained clinicians in certain regions can restrict access to advanced therapies, delaying treatment initiation and affecting outcomes
• Efforts to improve distribution networks, expand clinical training programs, and increase awareness among healthcare providers and patients are essential to overcome access limitations
• While clinical efficacy is well established, the combination of cost, access, and awareness challenges continues to hinder widespread adoption of advanced deep partial-thickness burn treatments

North America Deep Partial-Thickness Thermal Burns Treatment Market Scope

The market is segmented on the basis of burn type, treatment, route of administration, end user, and distribution channel.

• By Burn Type

On the basis of burn type, the market is segmented into fire burn injuries, scald burn, and hot objects. The fire burn injuries segment dominated the market with the largest revenue share of 52.5% in 2024, driven by the high incidence of fire-related accidents in residential and industrial settings. Fire burns are typically severe and penetrate deep partial-thickness layers, requiring advanced wound care, regenerative therapies, and long-term rehabilitation. Hospitals and specialty clinics prioritize fire burn treatment due to its complexity and high medical cost. Standardized treatment protocols, including surgical interventions and physical therapy, ensure consistent demand. The severity and prevalence of fire burns make this segment a critical revenue generator.

The scald burn segment is expected to witness the fastest growth rate of 11.5% from 2025 to 2032, fueled by increasing domestic and occupational scald incidents, especially among children and elderly populations. Scald burns require specialized care, including targeted dressings and close monitoring to prevent infection and scarring. Hospitals and home healthcare providers are adopting advanced wound care products and topical biologics for scald management. Public awareness campaigns about burn prevention are increasing the recognition and early treatment of scald injuries. The segment’s growth is further supported by the adoption of rehabilitation therapies that improve mobility and functional recovery. Rising consumer awareness and accessibility of treatment solutions make scald burns a high-growth segment.

• By Treatment

On the basis of treatment, the market is segmented into initial wound care, physical and occupational therapy, and others. The initial wound care segment dominated in 2024 with the largest revenue share of 47%, owing to its critical role in early burn management. Initial wound care involves cleansing, debridement, and application of advanced wound dressings or biologics to prevent infection and accelerate healing. Hospitals and specialty clinics rely on this phase to reduce complications such as hypertrophic scarring or contractures. Advanced antimicrobial and regenerative dressings enhance patient recovery and clinical outcomes. Standardized protocols in burn centers support steady demand. The segment’s dominance is sustained by repeat usage and the high volume of burn cases in medical facilities.

The physical and occupational therapy segment is expected to witness the fastest growth rate of 10.8% from 2025 to 2032, driven by increased focus on functional recovery and quality of life post-burn injury. Therapy interventions restore mobility, prevent contractures, and minimize long-term disability. Multidisciplinary rehabilitation programs in hospitals and home healthcare settings are boosting adoption. Technological advancements, including robotic and virtual reality-assisted therapy, enhance treatment outcomes. Awareness campaigns among patients and caregivers are emphasizing the importance of consistent rehabilitation. Early and continuous therapy improves overall recovery, contributing to segment growth.

• By Route of Administration

On the basis of route of administration, the market is segmented into topical, oral, and others. The topical segment dominated in 2024 with the largest revenue share of 62%, driven by widespread use of antimicrobial creams, hydrogel dressings, and bioengineered skin substitutes. Topical therapies offer targeted treatment, reduce systemic side effects, and accelerate tissue regeneration. Hospitals, specialty clinics, and home healthcare providers prefer topical solutions due to ease of application and clinical efficacy. Advanced formulations often integrate growth factors or stem-cell components to enhance healing. Their adaptability across various burn types sustains steady demand. Topical therapies are a critical part of standardized burn care protocols in North America.

The oral segment is expected to witness the fastest growth rate of 12.1% from 2025 to 2032, fueled by rising use of oral analgesics, anti-inflammatory agents, and nutritional supplements to support wound healing. Oral therapies complement topical and physical therapy interventions, improving overall patient outcomes. Increased awareness of holistic burn care and convenience of administration in home healthcare settings are driving adoption. Emerging research on oral regenerative supplements is further accelerating market growth. Patient adherence and preference for oral therapies enhance the segment’s growth potential. Healthcare providers are promoting oral interventions as part of comprehensive burn care plans.

• By End User

On the basis of end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others. The hospitals segment dominated with the largest revenue share of 58% in 2024, owing to their capacity to manage severe burns with surgical interventions, advanced wound care, and rehabilitation services. Hospitals are equipped with specialized burn units and multidisciplinary teams. The prevalence of fire and scald burns treated in hospitals reinforces this dominance. Hospitals act as key procurement centers for topical biologics, dressings, and devices, ensuring consistent demand. Well-established healthcare infrastructure in the U.S. supports widespread adoption of advanced therapies.

The home healthcare segment is expected to witness the fastest growth rate of 13.4% from 2025 to 2032, driven by rising preference for outpatient care, telemedicine support, and home-based burn management programs. Portable wound care solutions, remote monitoring devices, and patient education initiatives enable effective home-based treatment. Cost-effectiveness and convenience attract patients and caregivers to home healthcare services. Awareness campaigns about proper burn care and rehabilitation support adoption. Partnerships between providers and telehealth platforms further accelerate growth. The segment benefits from increasing availability of specialized products suitable for home use.

• By Distribution Channel

On the basis of distribution channel, the market is segmented into direct tender, hospital pharmacy, online pharmacy, retail pharmacy, and others. The direct tender segment dominated with the largest revenue share of 46% in 2024, driven by bulk procurement by hospitals and government agencies. Centralized purchasing ensures cost efficiency and consistent supply of burn care products. Tender contracts include advanced wound care products, biologics, and dressings, providing manufacturers with stable revenue. Hospitals and specialty clinics rely on direct tender for high-volume needs. The segment benefits from long-term agreements and recurring demand. Bulk purchasing reduces logistical and inventory challenges for healthcare providers.

The online pharmacy segment is expected to witness the fastest growth rate of 15.2% from 2025 to 2032, fueled by increasing e-commerce adoption and patient preference for home delivery of burn care products. Telehealth programs and home healthcare services are driving online procurement. Online channels provide convenience, competitive pricing, and access to specialty products not easily available locally. Patients increasingly rely on online pharmacies for timely delivery of dressings, topical biologics, and supplements. The growth of mobile applications and digital platforms enhances accessibility. Online pharmacy adoption is further supported by rising awareness of at-home care and self-management protocols.

North America Deep Partial-Thickness Thermal Burns Treatment Market Regional Analysis

• The U.S. dominated the North America deep partial-thickness thermal burns treatment market with the largest revenue share of 68.5% in 2024, supported by well-established healthcare infrastructure, high healthcare expenditure, and the presence of leading burn care providers
• Patients and healthcare providers in the region increasingly prioritize advanced wound care products, regenerative therapies, and comprehensive rehabilitation programs to improve clinical outcomes and minimize complications
• This widespread adoption is further supported by the presence of specialized burn centers, highly trained clinicians, and substantial healthcare expenditure, ensuring access to state-of-the-art burn management solutions

U.S. Deep Partial-Thickness Thermal Burns Treatment Market Insight

The U.S. deep partial-thickness thermal burns treatment market captured the largest revenue share in 2024 within North America, fueled by the high prevalence of burn injuries and advanced healthcare infrastructure. Hospitals and specialized burn centers are increasingly adopting regenerative therapies, advanced wound care products, and bioengineered skin substitutes to improve patient outcomes. Patients and caregivers are prioritizing faster healing, reduced scarring, and comprehensive rehabilitation programs, driving demand for innovative treatment options. The growing availability of home healthcare services for burn patients further supports market expansion. In addition, ongoing research and development, coupled with insurance coverage for advanced therapies, is facilitating broader adoption. The integration of clinical best practices with patient-centered care models is reinforcing the U.S. as the dominant market within North America.

Canada Deep Partial-Thickness Thermal Burns Treatment Market Insight

The Canada deep partial-thickness thermal burns treatment market is expected to grow at a substantial CAGR during the forecast period, driven by rising awareness of advanced burn care therapies and increasing healthcare investments. Canadian healthcare providers are adopting modern wound care solutions, regenerative products, and physical therapy programs to enhance recovery outcomes. Government initiatives promoting specialized burn care services are contributing to wider accessibility. The increasing prevalence of fire and scald burns in residential and industrial settings is fostering market demand. In addition, telehealth and home-based burn management programs are accelerating adoption across remote and urban areas. The combination of advanced infrastructure and patient-focused care is supporting steady market growth in Canada.

Mexico Deep Partial-Thickness Thermal Burns Treatment Market Insight

The Mexico deep partial-thickness thermal burns treatment market is expected to grow at a notable CAGR during the forecast period, driven by increasing awareness of advanced burn care and the rising prevalence of fire and scald injuries. Hospitals and specialty clinics in urban centers are increasingly adopting regenerative therapies, bioengineered skin substitutes, and advanced wound care products to improve patient outcomes. Home healthcare services and telemedicine programs are supporting access to treatment in remote areas, enhancing recovery and follow-up care. Government initiatives promoting burn prevention and specialized care infrastructure are further facilitating market growth. In addition, rising healthcare expenditure and investment in modern medical technologies are encouraging adoption of innovative treatment solutions. The combination of expanding healthcare infrastructure and growing patient awareness is establishing Mexico as a key emerging market within North America for deep partial-thickness burn treatments.

North America Deep Partial-Thickness Thermal Burns Treatment Market Share

The North America Deep Partial-Thickness Thermal Burns Treatment industry is primarily led by well-established companies, including:

• Convatec Group PLC (U.K.)
• Integra LifeSciences Corporation (U.S.)
• Medtronic (Ireland)
• Smith & Nephew (U.K.)
• Mölnlycke AB (Sweden)
• Derma Sciences, Inc. (U.S.)
• Acelity Inc. (U.S.)
• 3M (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Baxter (U.S.)
• Hollister Incorporated (U.S.)
• Coloplast A/S (Denmark)
• Medi-First (U.S.)
• Hollister Wound Care (U.S.)
• Molnlycke Health Care (U.S.)
• ThermaSolutions (U.S.)
• BurnShield (U.S.)

What are the Recent Developments in North America Deep Partial-Thickness Thermal Burns Treatment Market?

• In May 2025, a randomized, controlled trial was published comparing PermeaDerm® to Mepilex Ag® for the treatment of adult and pediatric partial-thickness burns. The study aimed to evaluate the effectiveness of these wound dressings in promoting healing and reducing complications in burn patients
• In April 2025, AVITA Medical presented 16 abstracts at the American Burn Association (ABA) Annual Meeting. The presentations highlighted real-world data and clinical findings on their portfolio of products, including the RECELL System, Cohealyx, and PermeaDerm. These presentations showcased the company's commitment to advancing burn and wound care with innovative technologies
• In August 2024, MediWound, a company specializing in severe burn and wound care, announced that the FDA had approved its product, NexoBrid, for use in pediatric patients with severe thermal burns. NexoBrid is a topical biological drug that enzymatically removes nonviable burn tissue, also known as eschar, without harming healthy tissue. This approval expands the use of this non-surgical debridement method to children, which is a major advancement in pediatric burn care
• In March 2023, ConvaTec received FDA clearance for InnovaBurn®, a placental extracellular matrix medical device designed to manage complex surgical wounds and partial-thickness second-degree burns. This innovative device is the first of its kind, offering a novel approach to burn care by utilizing placental-derived materials to promote healing and reduce the need for skin grafts
• In June 2021, the U.S. Food and Drug Administration (FDA) approved StrataGraft, a skin tissue product for the treatment of adult patients with deep partial-thickness thermal burns. This is a significant development as StrataGraft is an innovative regenerative tissue product that provides a durable wound closure without the need for a skin graft from the patient's own body (autograft)

SKU-65835